Forte Biosciences (FBRX) Revenue & Revenue Breakdown
Forte Biosciences Revenue Highlights
Forte Biosciences Revenue by Period
Forte Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $18.04M | 43890.24% |
| 2017-12-31 | $41.00K | -16.33% |
| 2016-12-31 | $49.00K | -3.92% |
| 2015-12-31 | $51.00K | - |
Forte Biosciences generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Forte Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $6.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $9.00K | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $9.00K | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | - |
Forte Biosciences generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Forte Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HOWL | Werewolf Therapeutics | $19.94M | $742.00K |
| ABVC | ABVC BioPharma | $152.43K | $117.14K |
| RZLT | Rezolute | - | - |
| FBRX | Forte Biosciences | - | - |
| CCCC | C4 Therapeutics | - | - |
| DBTX | Decibel Therapeutics | - | - |
| ERAS | Erasca | - | - |
| TPST | Tempest Therapeutics | - | - |
| CELC | Celcuity | - | - |
| INDP | Indaptus Therapeutics | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| KTTA | Pasithea Therapeutics | - | - |
FBRX Revenue FAQ
What is Forte Biosciences’s yearly revenue?
Forte Biosciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. FBRX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Forte Biosciences’s quarterly revenue?
Forte Biosciences's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $6K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). FBRX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Forte Biosciences’s revenue growth rate?
Forte Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.